Andrew Eng
About Andrew Eng
Andrew Eng is a Contracts Specialist currently working at Lyndra Therapeutics, with a background in biology and neuroscience. He has held various roles in technology licensing and research, including positions at MIT, the University of Pennsylvania, and Northwestern University.
Work at Lyndra Therapeutics
Andrew Eng has been serving as a Contracts Specialist at Lyndra Therapeutics since 2019. In this role, he is responsible for managing contracts and agreements related to the company's operations. His expertise in contract negotiation and management supports the organization's mission to develop innovative therapeutic solutions.
Previous Experience at MIT
Prior to his current position, Andrew Eng worked at the Massachusetts Institute of Technology (MIT) as a Technology Licensing Associate in Life Sciences from 2016 to 2019. During his three years there, he focused on licensing technologies developed within the institution, facilitating the transfer of innovations to commercial applications.
Educational Background
Andrew Eng holds a Bachelor of Arts in Biology from Boston University, where he studied from 2003 to 2007. He further pursued his education at Northwestern University, earning a PhD in Neuroscience from 2010 to 2016. Additionally, he studied at Waseda University for 11 months in 2004, enhancing his international academic experience.
Professional Roles in Neuroscience
Andrew Eng has held various positions in the field of neuroscience. He worked as a Laboratory Technician in the Neurosurgery department at the University of Pennsylvania from 2007 to 2010. He also served as an Undergraduate Student Researcher at Boston University in 2006-2007, contributing to research under the guidance of Dr. Maria Abate.
Experience in Innovation and New Ventures
In addition to his roles in academia, Andrew Eng has experience in innovation and new ventures. He worked as a Patentability and Marketing Analyst at the Innovation and New Ventures Office from 2015 to 2016, and briefly as an NXT Associate in 2016. These roles involved evaluating the commercial potential of new technologies and assisting in their development.